US 10899752
2,3-dihydro-4H-1,3-benzoxazin-4-one derivatives as modulators of cholinergic muscarinic M1 receptor
granted A61PA61P25/28
Quick answer
US patent 10899752 (2,3-dihydro-4H-1,3-benzoxazin-4-one derivatives as modulators of cholinergic muscarinic M1 receptor) held by Takeda Pharmaceutical Company Limited expires Mon Jan 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Jan 26 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61P, A61P25/28